114 related articles for article (PubMed ID: 37244434)
1. Contribution of skin cancer to overall healthcare costs of lung transplantation in Queensland, Australia.
Gordon LG; Hopkins PM; Chambers DC; Green AC
J Heart Lung Transplant; 2023 Oct; 42(10):1437-1444. PubMed ID: 37244434
[TBL] [Abstract][Full Text] [Related]
2. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
3. Keratinocyte cancer excisions in Australia: Who performs them and associated costs.
Thompson BS; Pandeya N; Olsen CM; Dusingize JC; Green AC; Neale RE; Whiteman DC
Australas J Dermatol; 2019 Nov; 60(4):294-300. PubMed ID: 31012087
[TBL] [Abstract][Full Text] [Related]
4. Clinical and economic burden of benign and malignant skin lesions in renal transplant recipients.
Thet Z; Lam AK; Pham T; Ng SK; Steel JC; Sawhney S; Arellano CT; Aung SY; Han T; Ranganathan D; John G; Pepito C; Rautenberg T; Khoo TK
Intern Med J; 2023 Nov; 53(11):2042-2049. PubMed ID: 36710434
[TBL] [Abstract][Full Text] [Related]
5. Skin cancer multiplicity in lung transplant recipients: a prospective population-based study.
Way M; Marquart L; Chambers DC; Hopkins P; Miura K; Jiyad Z; Plasmeijer EI; Ferguson LE; Davis M; Whiteman DC; Soyer HP; O'Rourke P; Green AC
Br J Dermatol; 2020 Sep; 183(3):503-508. PubMed ID: 31853948
[TBL] [Abstract][Full Text] [Related]
6. Effect of Transplant Center Volume on Cost and Readmissions in Medicare Lung Transplant Recipients.
Mooney JJ; Weill D; Boyd JH; Nicolls MR; Bhattacharya J; Dhillon GS
Ann Am Thorac Soc; 2016 Jul; 13(7):1034-41. PubMed ID: 27064753
[TBL] [Abstract][Full Text] [Related]
7. Multiplicity of skin cancers in Queensland and their cost burden to government and patients.
Gordon LG; Elliott TM; Olsen CM; Pandeya N; Whiteman DC
Aust N Z J Public Health; 2018 Feb; 42(1):86-91. PubMed ID: 29168287
[TBL] [Abstract][Full Text] [Related]
8. Estimated Healthcare Costs of Melanoma and Keratinocyte Skin Cancers in Australia and Aotearoa New Zealand in 2021.
Gordon LG; Leung W; Johns R; McNoe B; Lindsay D; Merollini KMD; Elliott TM; Neale RE; Olsen CM; Pandeya N; Whiteman DC
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328865
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States.
D'Arcy ME; Pfeiffer RM; Rivera DR; Hess GP; Cahoon EK; Arron ST; Brownell I; Cowen EW; Israni AK; Triplette MA; Yanik EL; Engels EA
JAMA Dermatol; 2020 Jul; 156(7):772-779. PubMed ID: 32401271
[TBL] [Abstract][Full Text] [Related]
10. Patient co-payments for women diagnosed with breast cancer in Australia.
Bates N; Callander E; Lindsay D; Watt K
Support Care Cancer; 2020 May; 28(5):2217-2227. PubMed ID: 31435727
[TBL] [Abstract][Full Text] [Related]
11. Cancer Survivors' Long-Term Health Service Costs in Queensland, Australia: Results of a Population-Level Data Linkage Study (Cos-Q).
Merollini KMD; Gordon LG; Ho YM; Aitken JF; Kimlin MG
Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35954835
[TBL] [Abstract][Full Text] [Related]
12. High-risk Prognostic Tumor Features of Squamous Cell Carcinomas in Organ Transplant Recipients Compared With the General Population.
Pandeya N; Isbel N; Campbell S; Chambers DC; Hopkins P; Soyer HP; Jiyad Z; Plasmeijer EI; Whiteman DC; Olsen CM; Green AC
JAMA Dermatol; 2023 Aug; 159(8):854-858. PubMed ID: 37314794
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Incidence Rate and Risk Factors for Keratoacanthoma Among Residents of Queensland, Australia.
Claeson M; Pandeya N; Dusingize JC; Thompson BS; Green AC; Neale RE; Olsen CM; Whiteman DC
JAMA Dermatol; 2020 Dec; 156(12):1324-1332. PubMed ID: 33026421
[TBL] [Abstract][Full Text] [Related]
14. The effects of a multidisciplinary high-throughput skin clinic on healthcare costs of organ transplant recipients.
Gordon LG; Rodriguez-Acevedo AJ; Papier K; Khosrotehrani K; Isbel N; Campbell S; Griffin A; Green AC
J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1290-1296. PubMed ID: 30706970
[TBL] [Abstract][Full Text] [Related]
15. Lifetime Costs of Surviving Cancer-A Queensland Study (COS-Q): Protocol of a Large Healthcare Data Linkage Study.
Merollini KMD; Gordon LG; Aitken JF; Kimlin MG
Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32326074
[TBL] [Abstract][Full Text] [Related]
16. Management of organ transplant recipients attending a high-throughput skin cancer surgery and surveillance clinic in Queensland.
Papier K; Gordon LG; Khosrotehrani K; Isbel N; Campbell S; Griffin A; Green AC
Br J Dermatol; 2019 Mar; 180(3):631-636. PubMed ID: 30005137
[TBL] [Abstract][Full Text] [Related]
17. Dermatological Disease in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon V; Glanville A; Parsi K
Dermatology; 2021; 237(4):629-634. PubMed ID: 32942278
[TBL] [Abstract][Full Text] [Related]
18. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.
Carroll RP; Ramsay HM; Fryer AA; Hawley CM; Nicol DL; Harden PN
Am J Kidney Dis; 2003 Mar; 41(3):676-83. PubMed ID: 12612993
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Skin Cancer and Related Skin Tumors in High-Risk Kidney and Liver Transplant Recipients in Queensland, Australia.
Iannacone MR; Sinnya S; Pandeya N; Isbel N; Campbell S; Fawcett J; Soyer PH; Ferguson L; Davis M; Whiteman DC; Green AC;
J Invest Dermatol; 2016 Jul; 136(7):1382-1386. PubMed ID: 26968258
[TBL] [Abstract][Full Text] [Related]
20. The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United States.
Sheshadri A; Sacks NC; Healey B; Cyr P; Boerner G; Huang HJ
J Med Econ; 2022; 25(1):650-659. PubMed ID: 35502563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
